NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in NeuroPace Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- +9 vs. Q1 2025
- Shares held
- 22.5M
- −1.43M (−6.0%) vs. Q1 2025
- Total value
- $250.7M
- −$43.4M (−14.8%) vs. Q1 2025
- New holders
- 22
- 46 more added
- Sold out
- 13
- 23 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NPCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 112 | $422.4M |
| Q1 2026 | 113 | $347.9M |
| Q4 2025 | 100 | $405.9M |
| Q3 2025 | 80 | $267.5M |
| Q2 2025 | 99 | $250.7M |
| Q1 2025 | 90 | $294.1M |
| Q4 2024 | 62 | $233.5M |
| Q3 2024 | 48 | $103.1M |
| Q2 2024 | 51 | $109.1M |
| Q1 2024 | 54 | $176.4M |
| Q4 2023 | 41 | $130.8M |
| Q3 2023 | 25 | $175.9M |
| Q2 2023 | 22 | $78.6M |
| Q1 2023 | 24 | $82.0M |
| Q4 2022 | 24 | $25.9M |
| Q3 2022 | 28 | $68.1M |
| Q2 2022 | 32 | $91.2M |
| Q1 2022 | 40 | $149.5M |
| Q4 2021 | 41 | $181.5M |
| Q3 2021 | 39 | $177.4M |
| Q2 2021 | 44 | $259.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding NeuroPace Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −2,972,003−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −268,716−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −123,346−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −30,400−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −27,766−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −24,867−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −20,700−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −17,873−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −11,083−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −6,949−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −378−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |